Discontinued — last reported Q4 '25
Change in Other Assets
OperatingEli Lilly Change in Other Assets remained flat by 0.0% to $1.65B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 98.4%, from $832.80M to $1.65B. Over 4 years (FY 2021 to FY 2025), Change in Other Assets shows an upward trend with a 44.5% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ4 2025
How to read this metric
Large swings are usually related to the timing of prepayments for services or long-term supply agreements.
Detailed definition
This captures the net change in miscellaneous operating assets not classified as receivables or inventory, such as prepa...
Peer comparison
This is typically a smaller component of cash flow for most large-cap technology firms unless they are securing long-term supply capacity.
Metric ID:
cf_change_in_other_assetsHistorical Data
5 years
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | -$1.52B | $793.50M | $3.45B | $3.33B | $6.61B |
| YoY Change | — | +152.4% | +335.2% | -3.5% | +98.4% |
Range-$1.52B – $6.61B
CAGR+44.5%
Avg YoY Growth+145.6%
Median YoY Growth+125.4%
Change in Other Assets at Other Companies
Frequently Asked Questions
- What is Eli Lilly's change in other assets?
- Eli Lilly (LLY) reported change in other assets of $1.65B in Q4 2025.
- How has Eli Lilly's change in other assets changed year-over-year?
- Eli Lilly's change in other assets increased by 98.4% year-over-year, from $832.80M to $1.65B.
- What is the long-term trend for Eli Lilly's change in other assets?
- Over 4 years (2021 to 2025), Eli Lilly's change in other assets has grown at a 44.5% compound annual growth rate (CAGR), from -$1.52B to $6.61B.
- What does change in other assets mean?
- The change in various other business assets like prepayments or miscellaneous deposits.